You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 33 No. 6, June 1976 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Neuroelectric Blocking Factors in Multiple Sclerosis and Normal Human Sera

Fredrick J. Seil, MD; Arnold L. Leiman, PhD; James M. Kelly III, MD

Arch Neurol. 1976;33(6):418-422.


Abstract

• Serum samples from 13 multiple sclerosis (MS) patients and ten normal human serum samples were applied to cerebral neocortex cultures and evaluated for their ability to block evoked electric activity. A high proportion of sera positive for neuroelectric blocking factors was found in both groups, and there was no substantial difference between serum samples from MS patients and those from normal human volunteers. Some of the neuroelectric blocking factors were thermolabile, others were thermostable, and still others may have been complementdependent. It is concluded that the ability to block evoked electric responses in tissue cultures is a nonspecific serum property, and that it is not specifically related to the pathogenesis of demyelinating disease.



Author Affiliations

From the Department of Neurology, Veterans Administration Hospital, Palo Alto, Calif (Drs Seil and Kelly) and the Department of Psychology, University of California, Berkeley (Dr Leiman).


Footnotes

Accepted for publication June 17, 1975.

A preliminary report of this work was presented at the sixth annual meeting of the American Society of Neurochemistry, Mexico City, March 13, 1975.

Reprint requests to Department of Neurology (180), Veterans Administration Hospital, Palo Alto, CA 94304 (Dr Seil).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The pentapeptide QYNAD does not block voltage-gated sodium channels
Cummins et al.
Neurology 2003;60:224-229.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1976 American Medical Association. All Rights Reserved.